Purchase Order 36C24224P0331
- Not listed
- This is a firm fixed-price purchase order awarded by the Veterans Integrated Service Network 2 (VISN 2), a civilian agency within the Department of Veterans Affairs (VA), to Roche Diagnostics Corporation for the procurement of VENTANA reagents and consumables. The contract has a ceiling value of $19,212.05 and an ultimate completion date of December 31, 2025. Roche Diagnostics Corporation is a leading manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and...
- This federal contract award to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, is for the delivery of VENTANA REAGENTS. The contract has a potential value of $305,627.54 and was awarded on February 25, 2020 by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 10. The contract is a Delivery Order with a Firm Fixed Price pricing type and does not have a set-aside designation. Roche Diagnostics is a manufacturer and...
- This federal contract award is for VENTANA REAGENTS provided by Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The contract was awarded by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 17, and has a potential value of $395,610.40. The contract type is a Purchase Order with a Firm Fixed Price pricing structure, and the period of...
- This federal contract was awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The $190,272.34 firm fixed-price purchase order is for the delivery of VENTANA REAGENTS with a completion date of November 24, 2021. Roche Diagnostics has provided critical care analyzers, reagents, test kits, and associated...
- This federal contract award to Roche Diagnostics Corporation, a manufacturer of in vitro diagnostics, reagents, and laboratory equipment, provides $553,387.58 in firm fixed-price funding for the supply of reagents and consumables. The contract was awarded on October 10, 2024 by the Department of Veterans Affairs' Veterans Integrated Service Network 22, a civilian agency, with an ultimate completion date of April 9, 2025. The contract is not set aside for any specific business type. Roche...
- This is a delivery order contract award to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, with a ceiling value of $379,792.16. The contract is for the provision of Roche Ventana reagents and consumables to the Veterans Integrated Service Network 17 of the Department of Veterans Affairs. The contract has no set-aside designation and is a firm fixed price, delivery order type contract with an ultimate completion date of December 31, 2023. Roche Diagnostics is an...
- The Department of Veterans Affairs Veterans Health Administration awarded a firm fixed-price purchase order to Roche Diagnostics Corporation, valued at $111,289.88, to provide Ventana benchmark reagents and consumables. This order was placed against Roche's existing Indefinite Delivery Contract with the Defense Health Agency, which allows the VA and other federal agencies to purchase Roche's chemistry reagents and supplies on an as-needed basis. Roche Diagnostics is a manufacturer and...
- This federal contract award is for the provision of VENTANA REAGENTS/ANCILLARIES by Roche Diagnostics Corporation, a foreign-owned for-profit manufacturer of in vitro diagnostics, laboratory instruments, and associated products and services. The $291,262.58 firm-fixed price contract was awarded by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 17 for performance in Dallas, TX. The contract does not have a set-aside designation. Roche...
- The Department of Veterans Affairs (VA) Veterans Health Administration awarded a purchase order contract to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, a foreign-owned for-profit manufacturer. The $161,459.20 firm-fixed-price contract is for the annual requirement of VENTANA reagents, with a completion date of January 12, 2021. Roche Diagnostics is a provider of in vitro diagnostics, reagents, laboratory instruments, and associated products and services to various...
- This federal contract award to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, has a ceiling value of $235,000.00. The contract is for the delivery of reagents and consumables, with a performance period through November 30, 2024. The award was made on December 1, 2023 by the Department of Veterans Affairs' Veterans Integrated Service Network 20. This is a Firm Fixed Price Delivery Order contract, without any set-aside designation. Roche Diagnostics is a major...
This federal contract award to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, is for the provision of VENTANA Reagents and Consumables. The contract is a Firm Fixed Price Purchase Order with a ceiling value of $233,295.52 and an ultimate completion date of July 31, 2024. The contract was awarded on December 10, 2023 by the Veterans Integrated Service Network 2, a civilian agency under the Department of Veterans Affairs. The contract does not have a set-aside designation. Roche Diagnostics is a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services, and has received numerous prime contract and subcontract awards from various federal agencies, including the Department of Veterans Affairs, Department of Defense, Department of Health and Human Services, and others, to provide critical medical equipment, supplies, and services.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Other Administrative Action | $19.8k | 6/11/24 | |
| Not listed | Not listed | $106.8k | 12/10/23 |